CD19 and COVID-19: Interestingly, just by analyzing the total CD19+ B cell fraction of PBMCs, we were able to detect differences in the frequency of these cells in COVID-19 patients when compared to healthy subjects, that although no significant, seem to be slightly increased particularly at severe and then critical cases (Figure 1B).